Ticker Scorecard - PYXS Basics Company: Pyxis Oncology, Inc. IPO Date: October 8, 2021 Sector: Healthcare Industry: Biotech Market Cap: $76.12M Activated in VL: True Average Daily Range Avg Daily Range: $0.16 | 3.98% Avg Daily Range (30 D): $0.04 | 2.38% Avg Daily Range (90 D): $0.08 | 3.28% Institutional Daily Volume Avg Daily Volume: .56M Avg Daily Volume (30 D): .55M Avg Daily Volume (90 D): .98M Trade Size Avg Trade Size (Sh.): 174 Avg Trade Size (Sh.) (30 D): 175 Avg Trade Size (Sh.) (90 D): 171 Institutional Trades Total Inst.Trades: 48 Avg Inst. Trade: $2.12M Avg Inst. Trade (30 D): $.93M Avg Inst. Trade (90 D): $.81M Avg Inst. Trade Volume: .53M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $4.71M Avg Closing Trade (30 D): $.93M Avg Closing Trade (90 D): $.9M Avg Closing Volume: 1.15M     News Jun 28, 2024 @ 8:30 PM Pyxis Oncology Reports Inducement Grants Under Nas... Source: Pyxis Oncology Jun 10, 2024 @ 11:30 AM Pyxis Oncology Expands Board of Directors with App... Source: Pyxis Oncology May 30, 2024 @ 11:30 AM Pyxis Oncology to Participate in a Fireside Chat a... Source: Pyxis Oncology May 14, 2024 @ 12:40 PM Pyxis Oncology, Inc. (PYXS) Reports Q1 Loss, Tops ... Source: Zacks Equity Research Apr 12, 2024 @ 1:55 PM Does Pyxis Oncology (PYXS) Have the Potential to R... Source: Zacks Equity Research Financials   TTM Q2 2024 Q1 2024 Basic EPS $-.35 $-.29 $-.06 Diluted EPS $-.35 $-.29 $-.06 Revenue $ M $ M $ 16.15M Gross Profit $ M $ M $ 15.67M Net Income / Loss $ -21.2M $ -17.3M $ -3.26M Operating Income / Loss $ -23.75M $ -20.03M $ -5.61M Cost of Revenue $ M $ M $ .48M Net Cash Flow $ -13.02M $ -2.89M $ 18.3M PE Ratio